Independent Non-Executive Director

Appointed: June 2016

Grahame is an experienced public company non-executive director, with over 20 years’ experience as an audit and risk committee chair. Grahame’s background is in investment banking, with 20 years’ experience of M&A, equity capital markets and corporate advisory.

Grahame started his career at Arthur Andersen, where he qualified as a chartered accountant. He became a director of corporate finance at Barclays de Zoete Wedd in 1993, and then joined UBS as a managing director, a member of its global investment banking management committee and global head of equity advisory. At UBS he was responsible for creating its industry sector teams, including technology and healthcare. In 2003 he became joint chief executive officer at WestLB Panmure where he built a pan-European business focused on growth companies and ran a €100 million technology fund. He advised the London Stock Exchange in 2003 on the creation of its TechMark growth segment.

Grahame sits on a number of technology and technology-rich healthcare company boards, both listed and unlisted. Grahame holds a Double First Class Honours degree from the University of Oxford. Grahame is a member of the Remuneration Committee, Nomination Committee and Audit, Risk and Valuations Committee and chaired the former, as well as serving as Senior Independent Director from appointment in 2016 until the AGM in 2025.